Erik Langhoff, MD, PhD
img_Erik Langhoff
PROFESSOR | Medicine, Nephrology
Treatment of Chronic Renal Failure

The Bronx VA is participating in a research study to explore the beneficial effect of lowering homocysteine levels in patients with chronic renal failure. Chronic renal failure is associated with elevated levels of homocysteine which can be significantly reduced by treatment with folate, B6, and B12. It is thought that elevated levels of homocysteine may lead to vascular events that cause increase risk of arterial thrombosis, coronary disease of cerebrovascular events. This study will follow these clinical endpoints. Dr. Langhoff's basic research interests are HIV-1, Cytomegalovirus, and Polyoma Virus.

BA, Soro Academy

MD, University of Copenhagen, Faculty of Medicine

PhD, University of Copenhagen, Faculty of Medicine

The Rockefeller

Massachusetts General Hospital

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Langhoff during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.


  • Bronx RHIO

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.